PanGenex Corporation Forms Exclusive Strategic Partnership with BulovaTech Labs

TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets: PGCX), a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has finalized a strategic partnership with BulovaTech Labs, Inc., (“LABS”), a wholly-owned subsidiary of Bulova Technologies Group Inc., (Pink Sheets: BLVT). The new partnership supports the joint development and commercialization of PanGenex’s nutraceutical and healthcare products. The partnership includes an exclusive collaboration agreement that will accelerate the development of proprietary technologies and products, which will be marketed by PanGenex under the PanGenex trademark.

Back to news